The Patent Finder

Terms ending in 2033

Tecan Genomics, Inc.

Every in-force patent on Tecan Genomics, Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,650,628Compositions and Methods for Targeted Nucleic Acid Sequence Enrichment and High Efficiency Library Generation
In force
 · High confidence
Tecan Genomics, Inc.In forceHigh confidence
US 10,036,012Compositions and Methods for Targeted Nucleic Acid Sequence Enrichment and High Efficiency Library Generation
In force
 · High confidence
Tecan Genomics, Inc.In forceHigh confidence
US 10,876,108Compositions and Methods for Targeted Nucleic Acid Sequence Enrichment and High Efficiency Library Generation
In force
 · Medium confidence
Tecan Genomics, Inc.In forceMedium confidence
US 11,697,843Methods for Creating Directional Bisulfite-Converted Nucleic Acid Libraries for Next Generation Sequencing
In force
 · Medium confidence
Tecan Genomics, Inc.In forceMedium confidence
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited